SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-042541
Filing Date
2018-02-13
Accepted
2018-02-13 16:15:16
Documents
6
Period of Report
2018-02-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d519809d8k.htm 8-K 17092
2 EX-99.1 d519809dex991.htm EX-99.1 10983
3 EX-99.2 d519809dex992.htm EX-99.2 27078
4 EX-99.3 d519809dex993.htm EX-99.3 12556
5 GRAPHIC g519809g06z17.jpg GRAPHIC 2979
6 GRAPHIC g519809g44g96.jpg GRAPHIC 175954
  Complete submission text file 0001193125-18-042541.txt   315600
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 18603503
SIC: 8731 Services-Commercial Physical & Biological Research